Busulfan
- Strength
- 6 mg/mL
- Form
- Injection
- Class
- Alkylating Drug
Amneal Pharmaceuticals LLC
Listed by Sagent Pharmaceuticals
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Alkylating Drug |
| Approval route | ANDA — approved generic |
| NDC code | 25021-241 |
| FDA application | ANDA207050 |
| RxNorm concept | 253113 |
| Package sizes listed | 1 |
| Marketed since | May 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Amneal Pharmaceuticals LLC
Hospira, Inc.
Eugia US LLC
Meitheal Pharmaceuticals Inc.
Meitheal Pharmaceuticals Inc.
Accord Healthcare, Inc
Pharmascience Inc.
busulfan
Waylis Therapeutics LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.